483
Bora Pharmaceuticals Injectables IncBora Pharmaceuticals Injectables Inc – FDA 483, Apr 9, 2014
Record Details
Cangene bioPharma, Inc. dba Emergent BioSolutions in Baltimore, MD, was cited for inadequate process performance qualification and validation for its HP Acthar Gel. The inspection revealed a lack of written procedures for production and process controls, specifically concerning batch size increases and associated documentation. This indicates significant deficiencies in ensuring drug product quality and purity.
View Company Profile
ID · b405fd36-830c-4638-831a-f978c0f67a51
Other documents for Bora Pharmaceuticals Injectables Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.